Parabilis Medicines, Inc. - Common Stock (PBLS)
Price History
Jun 12, 2026 — Sep 6, 2026Investment Snapshot
- P/B of 4.70 — trading above book value
- Piotroski F-Score 0/9 — signs of financial weakness
- Loss-making — negative ROE of -16.3%
Parabilis Medicines, Inc. - Common Stock (PBLS) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $4.9 billion . Key value metrics: P/B ratio 4.70, Piotroski F-Score 0 out of 9 .
Value Score
Key Metrics
Parabilis Medicines, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, PBLS shows a weak Piotroski F-Score of 0/9, a signal of deteriorating financial health, and negative return on equity of -16.3%, and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for PBLS is 45/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.